Compare Intuit Inc. (INTU) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intuit Inc. vs Oruka Therapeutics Inc. Common Stock — how do they compare? Intuit Inc. trades at $312 (market cap $82.96B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.08B). The key difference: Intuit Inc. is far larger — about 16.3× Oruka Therapeutics Inc. Common Stock's market cap, and Intuit Inc. pays a 1.78% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Intuit Inc. for 67 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| INTU | ORKA | |
|---|---|---|
Market Cap | $82.96B | $5.08B |
Volume | 2,923,762 | 685,276 |
Sector | Technology | Health |
52-Week High | $683.39 | $113.08 |
52-Week Low | $255.07 | $26.19 |
Typical Hold Time | 67 Days | 0 Days |
Enterprise Value | $84.18B | $4.21B |
Dividend Yield | 1.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Intuit (INTU) trades at $301.45, down 1.48% today, with strong fundamentals including 21.3% net income margin and consistent earnings beats. The stock shows bullish technical signals with support at $302 and resistance at $312. Revenue growth accelerated to $18.8B in 2025, while analyst consensus remains positive with a $379.68 price target. Recent news highlights class action lawsuits but also emphasizes growth in QuickBooks monetization and AI initiatives.
INTU presents a compelling growth story with robust profitability and analyst support, though legal overhangs and valuation near 52-week highs warrant caution. The company's focus on AI and new customer acquisition provides upside potential, but investors should monitor lawsuit developments and competitive pressures in the financial software sector.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intuit Inc.
Intuit is a provider of small-business accounting software (QuickBooks), personal tax solutions (TurboTax), and professional tax offerings (Lacerte). Founded in the mid-1980s, Intuit controls the majority of U.S. market share for small-business accounting and DIY tax-filing software.
Read more on INTU →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
